Shouheng Jin

Dr. Shouheng Jin


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2021 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
YWYaoxing Wu
Yaoxing Wu
LMLing Ma
Ling Ma
SCSihui Cai
Sihui Cai
ZZZhen Zhuang
Zhen Zhuang
ZZZhiyao Zhao
Zhiyao Zhao
JCJun Cui
Jun Cui
The ongoing 2019 novel coronavirus disease (COVID-19) caused by SARS-CoV-2 has posed a worldwide pandemic and a major global public health threat. The severity and mortality of COVID-19 are associated with virus-induced dysfunctional inflammatory responses and cytokine storms. However, the interplay between host inflammatory responses and SARS-CoV-2 infection remains largely unknown. Here, we demonstrate that SARS-CoV-2 nucleocapsid (N) protein, the major structural protein of the virion, promotes the virus-triggered activation of NF-κB signaling. After binding to viral RNA, N protein robustly undergoes liquid–liquid phase separation (LLPS), which recruits TAK1 and IKK complex, the key kinases of NF-κB signaling, to enhance NF-κB activation. Moreover, 1,6-hexanediol, the inhibitor of LLPS, can attenuate the phase separation of N protein and restrict its regulatory functions in NF-κB activation. These results suggest that LLPS of N protein provides a platform to induce NF-κB hyper-activation, which could be a potential therapeutic target against COVID-19 severe pneumonia.

21 August 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
CWChenglei Wu
Chenglei Wu
WCWeixin Chen
Weixin Chen
JHJincan He
Jincan He
SJShouheng Jin
Shouheng Jin
YLYukun Liu
Yukun Liu
WZWei Zhao
Wei Zhao
M 6 A controls the inflammatory response through cross-talk with H3K27me3, indicating the importance of m 6 A in immune homeostasis.

22 May 2019 in Autophagy
Verified
Journal Article
Closed access
HXHuifang Xian
Huifang Xian
SYShuai Yang
Shuai Yang
SJShouheng Jin
Shouheng Jin
YZYuxia Zhang
Yuxia Zhang
JCJun Cui
Jun Cui
DDX58/RIG-I, is a critical pattern recognition receptor for viral RNA, which plays an essential role in antiviral immunity. Its posttranslational modifications and stability are tightly regulated to mediate the moderate production of type I IFN to maintain the immune homeostasis. Recently, we reported that macroautophagy/autophagy balances type I IFN signaling through selective degradation of ISG15-associated DDX58 via LRRC25. However, the regulatory mechanism about the autophagic degradation of DDX58 remains largely undefined. Here, we identified LRRC59 as a vital positive regulator of DDX58-mediated type I IFN signaling. Upon virus infection, LRRC59 specifically interacted with ISG15-associated DDX58 and blocked its association with LRRC25, the secondary receptor to deliver DDX58 to autophagosomes for SQSTM1/p62-dependent degradation, leading to the stronger antiviral immune responses. Thus, our study reveals a novel regulatory role of selective autophagy in innate antiviral responses mediated by the cross-regulation of LRRC family members. These data further provide insights into the crosstalk between autophagy and innate immune responses.

26 April 2023 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
SCSihui Cai
Sihui Cai
CZChenqiu Zhang
Chenqiu Zhang
ZZZhen Zhuang
Zhen Zhuang
SZShengnan Zhang
Shengnan Zhang
LMLing Ma
Ling Ma
YWYaoxing Wu
Yaoxing Wu
Currently, the incidence and fatality rate of SARS-CoV-2 remain continually high worldwide. COVID-19 patients infected with SARS-CoV-2 exhibited decreased type I interferon (IFN-I) signal, along with limited activation of antiviral immune responses as well as enhanced viral infectivity. Dramatic progresses have been made in revealing the multiple strategies employed by SARS-CoV-2 in impairing canonical RNA sensing pathways. However, it remains to be determined about the SARS-CoV-2 antagonism of cGAS-mediated activation of IFN responses during infection. In the current study, we figure out that SARS-CoV-2 infection leads to the accumulation of released mitochondria DNA (mtDNA), which in turn triggers cGAS to activate IFN-I signaling. As countermeasures, SARS-CoV-2 nucleocapsid (N) protein restricts the DNA recognition capacity of cGAS to impair cGAS-induced IFN-I signaling. Mechanically, N protein disrupts the assembly of cGAS with its co-factor G3BP1 by undergoing DNA-induced liquid-liquid phase separation (LLPS), subsequently impairs the double-strand DNA (dsDNA) detection ability of cGAS. Taken together, our findings unravel a novel antagonistic strategy by which SARS-CoV-2 reduces DNA-triggered IFN-I pathway through interfering with cGAS-DNA phase separation.

22 January 2022 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
LZLingli Zhou
Lingli Zhou
XHXing He
Xing He
LWLiqiu Wang
Liqiu Wang
PWPing Wei
Ping Wei
ZCZhe CAI
Zhe CAI
JCJun Cui
Jun Cui

3 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
SJShouheng Jin
Shouheng Jin
XHXing He
Xing He
LMLing Ma
Ling Ma
ZZZhen Zhuang
Zhen Zhuang
YWYiliang Wang
Yiliang Wang
JCJun Cui
Jun Cui
In addition to investigating the virology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), discovering the host–virus dependencies are essential to identify and design effective antiviral therapy strategy. Here, we report that the SARS-CoV-2 entry receptor, ACE2, conjugates with small ubiquitin-like modifier 3 (SUMO3) and provide evidence indicating that prevention of ACE2 SUMOylation can block SARS-CoV-2 infection. E3 SUMO ligase PIAS4 prompts the SUMOylation and stabilization of ACE2, whereas deSUMOylation enzyme SENP3 reverses this process. Conjugation of SUMO3 with ACE2 at lysine (K) 187 hampers the K48-linked ubiquitination of ACE2, thus suppressing its subsequent cargo receptor TOLLIP-dependent autophagic degradation. TOLLIP deficiency results in the stabilization of ACE2 and elevated SARS-CoV-2 infection. In conclusion, our findings suggest selective autophagic degradation of ACE2 orchestrated by SUMOylation and ubiquitination as a potential way to combat SARS-CoV-2 infection.